General Cancer News
Top Stories
Celebrex-Lipitor Combo May Halt Prostate Cancer
POSTED: April 25, 2008Researchers at Rutgers' Ernest Mario School of Pharmacy have shown that administering a combination of the widely used drugs Celebrex (celecoxib, a nonsteroidal anti-inflammatory drug) and Lipitor (atorvastatin, a cholesterol lowering drug) stops the transition of early prostate cancer to its more aggressive and potentially fatal stage. Prostate canc...
Data Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up To 95% And Halts Metastasis In A Model Of Hormone-Refractory Prostate Cancer
POSTED: April 25, 2008Peregrine Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing targeted monoclonal antibodies for the treatment of cancer and hepatitis C virus (HCV) infection, announced that preclinical data presented at the 2008 Annual Meeting of the American Association for Cancer Research (AACR) shows that a mouse equivalent of Peregrine's a...
Blocking The Effect Of Inflammation-causing Cells Lowered Prostate Cancer Cells Invasion
POSTED: April 25, 2008Recent studies have suggested an association between chronic inflammation and cancers of the prostate, colon, stomach and liver. Now scientists at Northwestern University Feinberg School of Medicine report success in blocking an early step in metastasis of prostate cancer cells by interrupting the communication between the cancer cells and other cells t...
Evidence Is Lacking For Mistletoe As Cancer Treatment
POSTED: April 25, 2008It's probably best to use mistletoe to grab a quick smooch around Christmas time rather than as a supplement to help fight cancer, at least for now. More than 20 previous studies of mistletoe extracts were analyzed by the Cochrane Collaboration, a nonprofit organization that reviews health care research. The extracts are among the most pre...
Standard Chemo Works Better Against Metastatic BRCA1/2 Breast Cancer Than Against Sporadic Tumors
POSTED: April 25, 2008The first study to investigate the effects of chemotherapy on metastatic breast cancer in women with the BRCA1 or BRCA2 gene mutation has shown that standard chemotherapy works better in these patients than in women without the BRCA1/2 mutation. The authors of a study presented today (Thursday) at the 6th European Breast Cancer Conference (EBCC-6) in...
Study Findings From National Institutes Of Health Provide New Insights Into Breast Cancer Genetics
POSTED: April 25, 2008Researchers detail in 'Estrogen induces estrogen-related receptor alpha gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells,' new data in breast cancer. "Estrogen-related receptor alpha (ERRalpha), a member of the nuclear receptor superfamily, is closely related to the estrogen receptor...
New Type Of Drug Shrinks Primary Breast Cancer Tumors Significantly In Just 6 Weeks
POSTED: April 25, 2008A drug that targets the cell surface receptors that play an important role in many types of cancer can bring about significant tumour regression in breast cancer after only six weeks of use, a scientist told the 6th European Breast Cancer Conference (EBCC-6) today (Thursday 17 April). Dr. Angel Rodriguez, from the Lester and Sue Smith Breast Center, Bay...
New Chemotherapy Combo Produces Side Effects, But No Extra Efficacy, In Early Breast Cancer Patients
POSTED: April 25, 2008Adding capecitabine, a drug that inhibits DNA synthesis and slows the growth of tumour tissue, to docetaxel, in patients with early breast cancer, leads to more toxicities and does not improve the efficacy of treatment, a German scientist told the 6th European Breast Cancer Conference (EBCC-6) today (Thursday 17 April). Previously, such a combination ha...
MRI Before Surgery Leads To Better-adapted Treatment For Breast Cancer
POSTED: April 25, 2008The early use of magnetic resonance imaging (MRI) in women diagnosed with breast cancer can often lead to a better adapted surgical approach to the tumour, a scientist told the 6th European Breast Cancer Conference (EBCC-6) today (Wednesday April 16). Dr. David Martinez-Cecilia, a surgeon from the General Surgery Service, directed by Prof. Rufian-Pea, i...
Every Woman Is Urged To Talk To Her Healthcare Provider About Ways To Help Prevent Cervical Cancer
POSTED: April 25, 2008NEW YORK -- One4One, a unique program focused on empowering women to help make a difference in the fight against cervical cancer, starts today during National Minority Cancer Awareness Week. One4One urges women to talk to their healthcare provider about ways they can help protect themselves from cervical cancer, while also raising money to inc...
